Van beleggers
voor beleggers
desktop iconMarkt Monitor

Inloggen

  • Geen account? Registreren

Wachtwoord vergeten?

Aandeel RELIEF THERAPEUTICS N ZSE:RLF.CH, CH0100191136

  • 0,064 3 dec 2021 17:30
  • -0,001 (-1,54%) Dagrange 0,061 - 0,066
  • 8.477.634 Gem. (3M) 23,5M

Forum Relief therapeutics geopend

2 Posts
| Omlaag ↓
  1. IEX - Forummoderator 31 maart 2021 06:00
    ABOUT US
    Relief is a biopharmaceutical company founded by former Merck executives (Serono division) whose objective is to provide patients with therapeutic relief in serious diseases with high unmet medical need.

    We focus on clinical-stage programs based on molecules of natural origin (peptides and proteins) with a history of clinical use (well-established safety and tolerability) and either initial human activity with efficacy data (proof-of-concept) or a strong scientific rationale. Our most advanced programs involve our lead compound RLF-100™, a synthetic human vasoactive intestinal peptide (VIP) with multifaceted mode of action, in respiratory indications: COVID-19 induced lung injury with major near-term milestones and pulmonary sarcoidosis, two diseases for which no transformational therapy exists. Clinical development of RLF-100™ for other indications in both acute and chronic lung diseases are in planning stages.

    Groet Henk
2 Posts
|Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord

Direct naar Forum

RELIEF THERAPEUTICS N Meer »

Koers 0,064   Verschil 0,00 (-1,54%)
Laag 0,061   Volume 8.477.634
Hoog 0,066   Gem. Volume 23.496.559
3 dec 2021 17:30
Premium

KOPEN OF VERKOPEN?

Het laatste advies leest u als IEX Premium-lid

Ontdek Premium

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links